Screener
Astera Labs, Inc. ALAB Cash, Cash Equivalents, and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by Astera Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.
The source filing: Astera Labs, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001736297-26-000035
| Line item | As of June 30, 2026 / Level 1 | As of June 30, 2026 / Level 2 | Total Fair Value |
|---|---|---|---|
| Cash equivalents | |||
| Money market funds | $84,575 | — | $84,575 |
| Total cash equivalents | $84,575 | — | $84,575 |
| Marketable securities | |||
| U.S. treasury and agency securities | — | $227,172 | $227,172 |
| Commercial paper | — | 19,344 | 19,344 |
| Corporate debt securities | — | 894,989 | 894,989 |
| Total marketable securities | — | $1,141,505 | $1,141,505 |
ITEM 1. Financial Statements (Unaudited)
FAQ
- What is Astera Labs, Inc.'s cash, cash equivalents, and marketable securities?
- Astera Labs, Inc. (ALAB) reported cash, cash equivalents, and marketable securities of $1.14B in Q2 2026.
- How has Astera Labs, Inc.'s cash, cash equivalents, and marketable securities changed year-over-year?
- Astera Labs, Inc.'s cash, cash equivalents, and marketable securities increased by 11.2% year-over-year, from $1.03B to $1.14B.
- What is the long-term trend for Astera Labs, Inc.'s cash, cash equivalents, and marketable securities?
- Over 2 years (2023 to 2025), Astera Labs, Inc.'s cash, cash equivalents, and marketable securities has grown at a 210.8% compound annual growth rate (CAGR), from $105.69M to $1.02B.
- What does cash, cash equivalents, and marketable securities mean?
- This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.
Ask your AI about Astera Labs, Inc.'s cash, cash equivalents, and marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude